Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
Study Shows Superior Efficacy for TAXUS Express Stents Compared to Bare-Metal Stents in Heart Attack Patients at Two Years
Boston Scientific, 09/28/09
Boston Scientific Corporation announced two–year follow–up data from the HORIZONS–AMI trial. The trial, sponsored by the Cardiovascular Research Foundation with grant support from Boston Scientific and The Medicines Company, is designed to determine the safety and efficacy of the TAXUS Express2™ Paclitaxel–Eluting Coronary Stent System compared to bare–metal stenting in patients experiencing an acute myocardial infarction, or heart attack.
Today in Drug Trials...keeping you current
Receive free subspecialty "5-minute updates" via email
A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
New England Journal of Medicine, 11/20/09
Intravenous Drug Administration During Out-of-Hospital Cardiac Arrest: A Randomized Trial
JAMA, 11/25/09
Abbott to Acquire Novel Investigational Biologic to Treat Chronic Pain
Abbott, 11/16/09
Sponsor
Article Search
Sponsor


See Latest Articles


